NSE filing, NSE: LAXMIINDIA. Summary written from the filing by ALFA Finder's alert engine.
Laxmi India Finance Ltd: key numbers
- Share price
- ₹96.18
- Market cap
- ₹503.9 Cr
- Revenue (annual)
- ₹317.0 Cr
- Net profit (annual)
- ₹49.76 Cr
- P/E (TTM)
- 8.9×Sector 19.7×
- Promoter holding
- 60.17%+0.00% QoQ
- FII holding
- 1.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Laxmi India Finance Ltd
All →Laxmi India Finance Debt & Borrowing: ₹0.07 Cr
Laxmi India Finance Ltd paid monthly interest of Rs.0.07 Crore on its 3,000 secured NCDs on 28 October 2026. The payment was made on the due date, with no deviation reported.
- Value
- ₹0.07 Cr
Laxmi India Finance Debt & Borrowing: ₹0.36 Cr
Laxmi India Finance paid Rs. 0.36 Crore interest on its Rs. 50 Crore NCDs on 23 October 2026, before the due date. No delay was reported.
- Value
- ₹0.36 Cr
Laxmi India Finance Other Announcement
Laxmi India Finance Ltd submitted its quarterly shareholding pattern filing for the period ended September 30, 2026, in compliance with regulatory requirements.
Laxmi India Finance Debt & Borrowing: ₹0.86 Cr
Laxmi India Finance has completed the interest payment for its Series A and Series B Non-Convertible Debentures, totaling Rs. 0.86 Crore.
- Value
- ₹0.86 Cr
Laxmi India Finance Debt & Borrowing: ₹0.6 Cr
Laxmi India Finance Ltd has made an interest payment of Rs.0.60 Crore on its listed non-convertible debentures as per the payment schedule.
- Value
- ₹0.60 Cr
Laxmi India Finance Debt & Borrowing: ₹2.5 Cr
Laxmi India Finance Limited has completed a partial redemption of its rated, secured non-convertible debentures, with a principal repayment amounting to Rs. 2.50 Crore.
- Value
- ₹2.50 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date